Summers KM (2024), Genetic models of fibrillinopathies.

XB-ART-60517

Genetics 2024 Jan 03;2261:. doi: 10.1093/genetics/iyad189.

Show Gene links Show Anatomy links

Genetic models of fibrillinopathies.

Summers KM .

???displayArticle.abstract???
The fibrillinopathies represent a group of diseases in which the 10-12 nm extracellular microfibrils are disrupted by genetic variants in one of the genes encoding fibrillin molecules, large glycoproteins of the extracellular matrix. The best-known fibrillinopathy is Marfan syndrome, an autosomal dominant condition affecting the cardiovascular, ocular, skeletal, and other systems, with a prevalence of around 1 in 3,000 across all ethnic groups. It is caused by variants of the FBN1 gene, encoding fibrillin-1, which interacts with elastin to provide strength and elasticity to connective tissues. A number of mouse models have been created in an attempt to replicate the human phenotype, although all have limitations. There are also natural bovine models and engineered models in pig and rabbit. Variants in FBN2 encoding fibrillin-2 cause congenital contractural arachnodactyly and mouse models for this condition have also been produced. In most animals, including birds, reptiles, and amphibians, there is a third fibrillin, fibrillin-3 (FBN3 gene) for which the creation of models has been difficult as the gene is degenerate and nonfunctional in mice and rats. Other eukaryotes such as the nematode C. elegans and zebrafish D. rerio have a gene with some homology to fibrillins and models have been used to discover more about the function of this family of proteins. This review looks at the phenotype, inheritance, and relevance of the various animal models for the different fibrillinopathies.

???displayArticle.pubmedLink??? 37972149
???displayArticle.pmcLink??? PMC11021029
???displayArticle.link??? Genetics
???displayArticle.grants??? [+]

Species referenced: Xenopus tropicalis
Genes referenced: fbn1 fbn2 fbn3

???displayArticle.disOnts??? congenital contractural arachnodactyly [+]
???displayArticle.omims??? ACROMICRIC DYSPLASIA; ACMICD [+]
References [+] :

Adams, The Valley of Death in anticancer drug development: a reassessment. 2012, Pubmed

Adams, The Valley of Death in anticancer drug development: a reassessment. 2012, Pubmed
Anisimov, Cancer in rodents: does it tell us about cancer in humans? 2005, Pubmed
Aoyama, Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms. 1994, Pubmed
Arteaga-Solis, Regulation of limb patterning by extracellular microfibrils. 2001, Pubmed
Azumah, Candidate genes for polycystic ovary syndrome are regulated by TGFβ in the bovine foetal ovary. 2022, Pubmed
Bassnett, Zinn's zonule. 2021, Pubmed
Beene, Nonselective assembly of fibrillin 1 and fibrillin 2 in the rodent ocular zonule and in cultured cells: implications for Marfan syndrome. 2013, Pubmed
Bercher, mua-3, a gene required for mechanical tissue integrity in Caenorhabditis elegans, encodes a novel transmembrane protein of epithelial attachment complexes. 2001, Pubmed
Besser, An animal model of the Marfan syndrome. 1990, Pubmed
Bhatt, Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome. 2015, Pubmed
Blake, Mouse Genome Database (MGD): Knowledgebase for mouse-human comparative biology. 2021, Pubmed
Boizot, FBN2 Silencing Recapitulates Hypoxic Conditions and Induces Elastic Fiber Impairment in Human Dermal Fibroblasts. 2022, Pubmed
Bordini, Weighted gene co-expression network analysis identifies molecular pathways and hub genes involved in broiler White Striping and Wooden Breast myopathies. 2021, Pubmed
Boschiero, Genome-wide characterization of genetic variants and putative regions under selection in meat and egg-type chicken lines. 2018, Pubmed
Braverman, Bicuspid Aortic Valve in Marfan Syndrome. 2019, Pubmed
Bravo-Jaimes, Genetics in bicuspid aortic valve disease: Where are we? 2020, Pubmed
Burger, Molecular phenotyping and functional assessment of smooth muscle-like cells with pathogenic variants in aneurysm genes ACTA2, MYH11, SMAD3 and FBN1. 2021, Pubmed
Burke, Distribution of fibrillin I in extracellular matrix and epithelia during early development of avian embryos. 2000, Pubmed
Callewaert, Comprehensive clinical and molecular assessment of 32 probands with congenital contractural arachnodactyly: report of 14 novel mutations and review of the literature. 2009, Pubmed
Carta, Fibrillins 1 and 2 perform partially overlapping functions during aortic development. 2006, Pubmed
Casteleyn, Validation of the murine aortic arch as a model to study human vascular diseases. 2010, Pubmed
Charbonneau, In vivo studies of mutant fibrillin-1 microfibrils. 2010, Pubmed
Charbonneau, Microfibril structure masks fibrillin-2 in postnatal tissues. 2010, Pubmed
Charbonneau, Fine tuning of growth factor signals depends on fibrillin microfibril networks. 2004, Pubmed
Chaudhry, Fibrillin-1 regulates the bioavailability of TGFbeta1. 2007, Pubmed
Chaudhry, Mutation of the gene encoding fibrillin-2 results in syndactyly in mice. 2001, Pubmed
Chen, Truncated C-terminus of fibrillin-1 induces Marfanoid-progeroid-lipodystrophy (MPL) syndrome in rabbit. 2018, Pubmed
Collod-Béroud, Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database. 2003, Pubmed
Cook, Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome. 2015, Pubmed
Cook, Generation of Fbn1 conditional null mice implicates the extracellular microfibrils in osteoprogenitor recruitment. 2012, Pubmed
Corson, Differential expression of fibrillin-3 adds to microfibril variety in human and avian, but not rodent, connective tissues. 2004, Pubmed
Culetto, A role for Caenorhabditis elegans in understanding the function and interactions of human disease genes. 2000, Pubmed
Davis, Stability of elastin in the developing mouse aorta: a quantitative radioautographic study. 1993, Pubmed
Davis, Transcriptional profiling of the human fibrillin/LTBP gene family, key regulators of mesenchymal cell functions. 2014, Pubmed
Davis, Expression of FBN1 during adipogenesis: Relevance to the lipodystrophy phenotype in Marfan syndrome and related conditions. 2016, Pubmed
Davis, Structure and function of the mammalian fibrillin gene family: implications for human connective tissue diseases. 2012, Pubmed
De Backer, Looking for the Missing Links: Challenges in the Search for Genotype-Phenotype Correlation in Marfan Syndrome. 2018, Pubmed
de Jong, Of mice and humans: are they the same?--Implications in cancer translational research. 2010, Pubmed
de Souza, Association of thoracic spine deformity and cardiovascular disease in a mouse model for Marfan syndrome. 2019, Pubmed
Dietz, Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. 1991, Pubmed
Dietz, Recent progress towards a molecular understanding of Marfan syndrome. 2005, Pubmed
Dixon, Mutation of the Na-K-Cl co-transporter gene Slc12a2 results in deafness in mice. 1999, Pubmed
Duerrschmid, Asprosin is a centrally acting orexigenic hormone. 2017, Pubmed
Elsea, The mousetrap: what we can learn when the mouse model does not mimic the human disease. 2002, Pubmed
Esterly, Stiff skin syndrome. 1971, Pubmed
Faivre, Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. 2007, Pubmed
Faivre, Clinical homogeneity and genetic heterogeneity in Weill-Marchesani syndrome. 2003, Pubmed
Faivre, In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. 2003, Pubmed
Faivre, Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations. 2009, Pubmed
Fernández, Bicuspid Aortic Valve in 2 Model Species and Review of the Literature. 2020, Pubmed
Folkestad, Bone Geometry, Density, and Microarchitecture in the Distal Radius and Tibia in Adults With Marfan Syndrome Assessed by HR-pQCT. 2020, Pubmed
Forrest, A promoter-level mammalian expression atlas. 2014, Pubmed
Fotopoulos, DPY-17 and MUA-3 Interact for Connective Tissue-Like Tissue Integrity in Caenorhabditis elegans: A Model for Marfan Syndrome. 2015, Pubmed
Frand, Functional genomic analysis of C. elegans molting. 2005, Pubmed
Franken, Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan Syndrome. 2015, Pubmed
Frédéric, The FBN2 gene: new mutations, locus-specific database (Universal Mutation Database FBN2), and genotype-phenotype correlations. 2009, Pubmed
Gaj, Genome-Editing Technologies: Principles and Applications. 2016, Pubmed
Geister, Optimizing Genomic Methods for Mapping and Identification of Candidate Variants in ENU Mutagenesis Screens Using Inbred Mice. 2018, Pubmed
Gerber, Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma. 2013, Pubmed
Getz, Animal models of atherosclerosis. 2012, Pubmed
Gheyas, Functional classification of 15 million SNPs detected from diverse chicken populations. 2015, Pubmed
Gibbs, Genome sequence of the Brown Norway rat yields insights into mammalian evolution. 2004, Pubmed
Gigante, Elastic fibers of musculoskeletal tissues in bovine Marfan syndrome: a morphometric study. 1999, Pubmed
Girdauskas, Genetic abnormalities in bicuspid aortic valve root phenotype: preliminary results. 2017, Pubmed
Glasauer, Whole-genome duplication in teleost fishes and its evolutionary consequences. 2014, Pubmed
Godfrey, Cosegregation of elastin-associated microfibrillar abnormalities with the Marfan phenotype in families. 1990, Pubmed
Goldblatt, Further evidence for a marfanoid syndrome with neonatal progeroid features and severe generalized lipodystrophy due to frameshift mutations near the 3' end of the FBN1 gene. 2011, Pubmed
Gould, ADAMTS17 mutation associated with primary lens luxation is widespread among breeds. 2011, Pubmed
Gramates, FlyBase: a guided tour of highlighted features. 2022, Pubmed
Graul-Neumann, Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3' terminus of the FBN1-gene. 2010, Pubmed
Green, Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton. 1976, Pubmed
Gupta, Ten novel FBN2 mutations in congenital contractural arachnodactyly: delineation of the molecular pathogenesis and clinical phenotype. 2002, Pubmed
Habashi, Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. 2006, Pubmed
Hamosh, Online Mendelian Inheritance in Man (OMIM). 2000, Pubmed
Hecht, "New" syndrome of congenital contractural arachnodactyly originally described by Marfan in 1896. 1972, Pubmed
Hirani, LTBP-2 specifically interacts with the amino-terminal region of fibrillin-1 and competes with LTBP-1 for binding to this microfibrillar protein. 2007, Pubmed
Hirano, Identification of an FBN1 mutation in bovine Marfan syndrome-like disease. 2012, Pubmed
Hollister, Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome. 1990, Pubmed
Hopper, Comparative Study of Human and Murine Aortic Biomechanics and Hemodynamics in Vascular Aging. 2021, Pubmed
Horn, Progeroid facial features and lipodystrophy associated with a novel splice site mutation in the final intron of the FBN1 gene. 2011, Pubmed
Hubmacher, Genetic and functional linkage between ADAMTS superfamily proteins and fibrillin-1: a novel mechanism influencing microfibril assembly and function. 2011, Pubmed
Hubmacher, Human eye development is characterized by coordinated expression of fibrillin isoforms. 2014, Pubmed
Hume, Fate-mapping studies in inbred mice: A model for understanding macrophage development and homeostasis? 2023, Pubmed
Hytönen, Canine models of human rare disorders. 2016, Pubmed
Idoko-Akoh, Generation of Genome-Edited Chicken Through Targeting of Primordial Germ Cells. 2023, Pubmed
Isogai, Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. 2003, Pubmed
Jack, Genetically engineered animal models for Marfan syndrome: challenges associated with the generation of pig models for diseases caused by haploinsufficiency. 2022, Pubmed
Jacquinet, Neonatal progeroid variant of Marfan syndrome with congenital lipodystrophy results from mutations at the 3' end of FBN1 gene. 2014, Pubmed
Johnson, The original shaker-with-syndactylism mutation (sy) is a contiguous gene deletion syndrome. 1998, Pubmed
Jones, Targeted deletion of fibrillin-1 in the mouse eye results in ectopia lentis and other ocular phenotypes associated with Marfan syndrome. 2019, Pubmed
Jordan, Fibrillins in adult human ovary and polycystic ovary syndrome: is fibrillin-3 affected in PCOS? 2010, Pubmed
Judge, Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. 2004, Pubmed
Judge, Marfan's syndrome. 2005, Pubmed
Kaldunski, Rare disease research resources at the Rat Genome Database. 2023, Pubmed
Keane, Mouse genomic variation and its effect on phenotypes and gene regulation. 2011, Pubmed
Kielty, Fell-Muir Lecture: Fibrillin microfibrils: structural tensometers of elastic tissues? 2017, Pubmed
Krishnan, A detailed comparison of mouse and human cardiac development. 2014, Pubmed
Lau, High-Fat Diet Has a Protective Sex-Dependent Effect on Aortic Aneurysm Severity in a Marfan Syndrome Mouse Model. 2023, Pubmed
Lee, Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. 1991, Pubmed
Levkovitch-Verbin, Animal models of optic nerve diseases. 2004, Pubmed
Li, Generation of a human iPSC line from a patient with Marfan syndrome caused by mutation in FBN1. 2019, Pubmed
Lilue, Sixteen diverse laboratory mouse reference genomes define strain-specific haplotypes and novel functional loci. 2018, Pubmed
Lima, A new mouse model for marfan syndrome presents phenotypic variability associated with the genetic background and overall levels of Fbn1 expression. 2010, Pubmed
Lin, Genetic and molecular mechanism for distinct clinical phenotypes conveyed by allelic truncating mutations implicated in FBN1. 2020, Pubmed
Liu, The stiff skin syndrome: case series, differential diagnosis of the stiff skin phenotype, and review of the literature. 2008, Pubmed
Loeys, The revised Ghent nosology for the Marfan syndrome. 2010, Pubmed
Loscalzo, Familial thoracic aortic dilation and bicommissural aortic valve: a prospective analysis of natural history and inheritance. 2007, Pubmed
Lyons, Feline genetics: clinical applications and genetic testing. 2010, Pubmed
Mariencheck, Fibrillin-1 and fibrillin-2 show temporal and tissue-specific regulation of expression in developing elastic tissues. 1995, Pubmed
Martin, Ensembl 2023. 2023, Pubmed
Maslen, Partial sequence of a candidate gene for the Marfan syndrome. 1991, Pubmed
Massam-Wu, Assembly of fibrillin microfibrils governs extracellular deposition of latent TGF beta. 2010, Pubmed
Matt, Circulating transforming growth factor-beta in Marfan syndrome. 2009, Pubmed
Maumenee, The eye in the Marfan syndrome. 1981, Pubmed
Maynard, Mouse Models and Online Resources for Functional Analysis of Osteoporosis Genome-Wide Association Studies. 2019, Pubmed
Mayne, Morphological and biochemical studies of the structure of the vitreous and the zonular fibres. 1991, Pubmed
Meek, From engineering to editing the rat genome. 2017, Pubmed
Michelena, International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes. 2021, Pubmed
Milewicz, Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts. 1992, Pubmed
Miller, ENU mutagenesis reveals a novel phenotype of reduced limb strength in mice lacking fibrillin 2. 2010, Pubmed
Milleron, Marfan Sartan: a randomized, double-blind, placebo-controlled trial. 2015, Pubmed
Morris, The quail genome: insights into social behaviour, seasonal biology and infectious disease response. 2020, Pubmed
Nagase, Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. 2001, Pubmed
Nataatmadja, Overexpression of transforming growth factor-beta is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm. 2006, Pubmed
Nataatmadja, Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm. 2003, Pubmed
Neptune, Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. 2003, Pubmed
Ng, SIFT: Predicting amino acid changes that affect protein function. 2003, Pubmed
Nohmi, Transgenic rat models for mutagenesis and carcinogenesis. 2017, Pubmed
Orozco, Copy number variation influences gene expression and metabolic traits in mice. 2009, Pubmed
Ostrander, The canine genome. 2005, Pubmed
Pan, Generation of an induced pluripotent stem cell line from a patient carrying FBN1/c.6734 G > A mutation. 2021, Pubmed
Parker, Genetic structure of the purebred domestic dog. 2004, Pubmed
Parker, Canine genomics and genetics: running with the pack. 2005, Pubmed
Payen, Primary lens instability in ten related cats: clinical and genetic considerations. 2011, Pubmed
Peeters, The fibrillinopathies: New insights with focus on the paradigm of opposing phenotypes for both FBN1 and FBN2. 2022, Pubmed
Pepe, Identification of fibrillin 1 gene mutations in patients with bicuspid aortic valve (BAV) without Marfan syndrome. 2014, Pubmed
Pereira, Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. 1997, Pubmed
Pereira, Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. 1999, Pubmed
Perlman, Mouse models of human disease: An evolutionary perspective. 2016, Pubmed
Piccolo, Skin fibroblasts of patients with geleophysic dysplasia due to FBN1 mutations have lysosomal inclusions and losartan improves their microfibril deposition defect. 2019, Pubmed
Piha-Gossack, The evolution of extracellular fibrillins and their functional domains. 2012, Pubmed
Pitcher, Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials. 2022, Pubmed
Potter, Cardiovascular lesions in bovine Marfan syndrome. 1994, Pubmed
Potter, Abnormal fibrillin metabolism in bovine Marfan syndrome. 1993, Pubmed
Pradhan, An Efficient Method for Generation of Transgenic Rats Avoiding Embryo Manipulation. 2016, Pubmed
Prodoehl, Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries. 2009, Pubmed
Prodoehl, Fibrillins and latent TGFbeta binding proteins in bovine ovaries of offspring following high or low protein diets during pregnancy of dams. 2009, Pubmed
Putnam, Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly. 1995, Pubmed
Pyeritz, The Marfan syndrome. 2000, Pubmed
Pyeritz, Marfan syndrome: improved clinical history results in expanded natural history. 2019, Pubmed
Qin, Reprogramming of a human induced pluripotent stem cell line from a Marfan syndrome patient harboring a heterozygous mutation of c.2939G > A in FBN1 gene. 2021, Pubmed
Quint, Zebrafish: An In Vivo Screening Model to Study Ocular Phenotypes. 2022, Pubmed
Robertson, TB domain proteins: evolutionary insights into the multifaceted roles of fibrillins and LTBPs. 2011, Pubmed
Robinson, The molecular genetics of Marfan syndrome and related microfibrillopathies. 2000, Pubmed
Romere, Asprosin, a Fasting-Induced Glucogenic Protein Hormone. 2016, Pubmed
Rongish, Identification of the developmental marker, JB3-antigen, as fibrillin-2 and its de novo organization into embryonic microfibrous arrays. 1998, Pubmed , Xenbase
Ruberte, Bridging mouse and human anatomies; a knowledge-based approach to comparative anatomy for disease model phenotyping. 2023, Pubmed
Rueda-Martínez, Fibrillin 2 is upregulated in the ascending aorta of patients with bicuspid aortic valve. 2017, Pubmed
Sabatier, Fibrillin-3 expression in human development. 2011, Pubmed
Sandor, A randomized, double blind pilot study to assess the effects of losartan vs. atenolol on the biophysical properties of the aorta in patients with Marfan and Loeys-Dietz syndromes. 2015, Pubmed
Sayers, Database resources of the national center for biotechnology information. 2022, Pubmed
Schrijver, Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes. 1999, Pubmed
Schrijver, Premature termination mutations in FBN1: distinct effects on differential allelic expression and on protein and clinical phenotypes. 2002, Pubmed
Schulte, Study design quality of research on dogs published in peer-reviewed journals. 2022, Pubmed
Sengle, The fibrillin microfibril scaffold: A niche for growth factors and mechanosensation? 2015, Pubmed
Sengle, Microenvironmental regulation by fibrillin-1. 2012, Pubmed
Senter, A critical survey of vestigial structures in the postcranial skeletons of extant mammals. 2015, Pubmed
Shapiro, Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weapons-related radiocarbon. 1991, Pubmed
Shen, A review of the underlying genetics and emerging therapies for canine cardiomyopathies. 2022, Pubmed
Singleton, Bovine model of Marfan syndrome results from an amino acid change (c.3598G > A, p.E1200K) in a calcium-binding epidermal growth factor-like domain of fibrillin-1. 2005, Pubmed
Siracusa, A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. 1996, Pubmed
Song, Genome engineering technologies in rabbits. 2020, Pubmed
Soto-Navarrete, Experimental evidence of the genetic hypothesis on the etiology of bicuspid aortic valve aortopathy in the hamster model. 2022, Pubmed
Souza, The mgΔlpn mouse model for Marfan syndrome recapitulates the ocular phenotypes of the disease. 2021, Pubmed
Streeten, Immunohistochemical comparison of ocular zonules and the microfibrils of elastic tissue. 1981, Pubmed
Streeten, The protein composition of the ocular zonules. 1983, Pubmed
Sugahara, Anti-skin-aging effects of human ceramides via collagen and fibrillin expression in dermal fibroblasts. 2022, Pubmed
Summers, Fibrillin-1 and asprosin, novel players in metabolic syndrome. 2023, Pubmed
Summers, Co-expression of FBN1 with mesenchyme-specific genes in mouse cell lines: implications for phenotypic variability in Marfan syndrome. 2010, Pubmed
Takeda, Congenital contractural arachnodactyly complicated with aortic dilatation and dissection: Case report and review of literature. 2015, Pubmed
Takenouchi, Severe congenital lipodystrophy and a progeroid appearance: Mutation in the penultimate exon of FBN1 causing a recognizable phenotype. 2013, Pubmed
Tsang, Large animal models of cardiovascular disease. 2016, Pubmed
Umeyama, Generation of heterozygous fibrillin-1 mutant cloned pigs from genome-edited foetal fibroblasts. 2016, Pubmed
Urbanek, Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype. 2007, Pubmed
Velvin, Systematic review of the psychosocial aspects of living with Marfan syndrome. 2015, Pubmed
Wessels, Developmental anatomy of the heart: a tale of mice and man. 2003, Pubmed
Whitelaw, Engineering large animal models of human disease. 2016, Pubmed
Wright, Immunization with undenatured bovine zonular fibrils results in monoclonal antibodies to fibrillin. 1994, Pubmed
Wu, BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. 2009, Pubmed
Yates, Ensembl Genomes 2022: an expanding genome resource for non-vertebrates. 2022, Pubmed
Yin, CRISPR/Cas9 in zebrafish: An attractive model for FBN1 genetic defects in humans. 2021, Pubmed
Yu, Placensin is a glucogenic hormone secreted by human placenta. 2020, Pubmed
Yu, Generation of Marfan patient specific iPSCs (ICSSUi001-A) carrying a novel heterozygous mutation in FBN1 gene. 2022, Pubmed
Zernii, Rabbit Models of Ocular Diseases: New Relevance for Classical Approaches. 2016, Pubmed
Zhang, Elastic Fibre Proteins in Elastogenesis and Wound Healing. 2022, Pubmed
Zhang, Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices. 1994, Pubmed
Zhu, Characterization of muscle development and gene expression in early embryos of chicken, quail, and their hybrids. 2021, Pubmed